SMTL ID : 6ljt.1

Crystal structure of human FABP4 in complex with a novel inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.45 Å

Oligo State

monomer

Ligands

1 x EH6: 2-[(3-chloranyl-2-phenyl-phenyl)amino]benzoic acid(Non-covalent)

EH6.1: 15 residues within 4Å: Chain A: F.37, A.54, A.57, P.59, S.76, F.78, A.96, D.97, R.99, I.125, R.127, V.136, R.147, Y.149 Ligands: EDO.2 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:F.37, A:A.54, A:A.57, A:P.59, A:A.96, A:I.125, A:I.125, A:V.136 Hydrogen bonds: A:Y.149 Water bridges: A:S.74 Salt bridges: A:R.147 pi-Stacking: A:F.37, A:F.78

1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.2: 5 residues within 4Å: Chain A: I.72, T.81, I.83, R.127 Ligands: EH6.1 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:T.81, A:R.127 Water bridges: A:S.74, A:S.74, A:E.93

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Su, H. et al., Exploration of Fragment Binding Poses Leading to Efficient Discovery of Highly Potent and Orally Effective Inhibitors of FABP4 for Anti-inflammation. J.Med.Chem. (2020)

Release Date

2020-04-15

Peptides

Fatty acid-binding protein, adipocyte: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Fatty acid-binding protein, adipocyte

Related Entries With Identical Sequence